Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
- PMID: 15249616
- DOI: 10.1212/01.wnl.0000129544.79539.d5
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
Abstract
Objective: To assess neocortical changes and their relevance to cognitive impairment in early relapsing-remitting (RR) multiple sclerosis (MS).
Methods: Conventional MR was acquired in 41 patients with RR MS and 16 demographically matched normal control subjects (NCs). An automated analysis tool was used with conventional T1-weighted MRI to obtain measures of cortical brain volumes normalized for head size. Neuropsychological performance of MS patients was assessed using the Rao Brief Repeatable Battery. Relationship between volumetric MR measures and neuropsychological scores was assessed.
Results: Neuropsychological assessment allowed for the identification of 18 cognitively preserved (MS-cp) and 23 cognitively impaired (MS-ci) MS patients. The whole MS sample showed lower values of normalized cortical volumes (NCVs) than did the NC group (p = 0.01). Upon grouping of MS patients according to cognitive performance, NCV values were lower (p = 0.02) in MS-ci patients than in both MS-cp patients and NCs. Moreover, there were positive correlations between NCV values and measures of verbal memory (r = 0.51, p = 0.02), verbal fluency (r = 0.51, p = 0.01), and attention/concentration (r = 0.65, p < 0.001) in MS-ci patients. Furthermore, NCV values were decreased in patients who scored lower on a greater number of tests (r = -0.58, p < 0.01) in the MS-ci group. None of the neuropsychological measures correlated to NCV values in the MS-cp patient group.
Conclusions: Cortical atrophy was found only in cognitively impaired patients and was significantly correlated with a poorer performance on tests of verbal memory, attention/concentration, and verbal fluency. Gray matter pathology may contribute to the development of cognitive impairment in MS from the earliest stages of the disease.
Similar articles
-
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.J Neurol Sci. 2006 Jun 15;245(1-2):195-9. doi: 10.1016/j.jns.2005.07.019. Epub 2006 Apr 24. J Neurol Sci. 2006. PMID: 16631794
-
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174. Arch Neurol. 2009. PMID: 19752305
-
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.Arch Neurol. 2007 Aug;64(8):1157-61. doi: 10.1001/archneur.64.8.1157. Arch Neurol. 2007. PMID: 17698706
-
Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.J Neurol Sci. 2002 Mar 30;195(2):103-9. doi: 10.1016/s0022-510x(01)00690-6. J Neurol Sci. 2002. PMID: 11897239
-
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.Neurology. 2003 Apr 8;60(7):1157-62. doi: 10.1212/01.wnl.0000055926.69643.03. Neurology. 2003. PMID: 12682324 Clinical Trial.
Cited by
-
Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis.Front Mol Neurosci. 2022 Oct 19;15:1024058. doi: 10.3389/fnmol.2022.1024058. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36340686 Free PMC article. Review.
-
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.PLoS One. 2012;7(11):e44826. doi: 10.1371/journal.pone.0044826. Epub 2012 Nov 5. PLoS One. 2012. PMID: 23144775 Free PMC article.
-
Cortical atrophy is relevant in multiple sclerosis at clinical onset.J Neurol. 2007 Sep;254(9):1212-20. doi: 10.1007/s00415-006-0503-6. Epub 2007 Mar 14. J Neurol. 2007. PMID: 17361339
-
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.Neuropsychopharmacology. 2011 Feb;36(3):559-68. doi: 10.1038/npp.2010.187. Epub 2010 Oct 13. Neuropsychopharmacology. 2011. PMID: 20944553 Free PMC article.
-
Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers.Brain Commun. 2022 Jul 8;4(4):fcac153. doi: 10.1093/braincomms/fcac153. eCollection 2022. Brain Commun. 2022. PMID: 35813883 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous